
Crossandra Pharma Private Limited
About Crossandra Pharma Private Limited
Data last updated:
Crossandra Pharma Private Limited is a private limited company based in Aurangabad, Maharashtra, India. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 02 June 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2016PTC281931. Its GSTIN is 27AAGCC4879C1ZJ (Maharashtra).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Sarika Anil Kamble and Anil Sadashivrao Kamble.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at Flat No. 04 S No 8/2 A – 1 Bldg Ahinsa Nisarga Bhavsing Pura Power House Road Chavani, Aurangabad, Maharashtra, India – 431001.
As per the financials filed for FY 2024, the company reported a revenue of ₹30.77 Lakh, a decline of 1% compared to the previous year. For the same year it recorded a net profit of ₹68,992 (net margin 2.2%) and EBITDA of ₹93,232 (EBITDA margin 3%). Revenue has grown at a compounded annual rate (CAGR) of 5% over three years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Crossandra Pharma Private Limited's registered office is in Aurangabad, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressFlat No. 04 S No 8/2 A – 1 Bldg Ahinsa Nisarga Bhavsing Pura Power House Road Chavani, Aurangabad, Maharashtra, India – 431001
- IndustryChemicals, Manufacturing, Other Chemical Product
To see the full contact details of Crossandra Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Crossandra Pharma is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Crossandra Pharma Private Limited, buy the company report.
Financials of Crossandra Pharma Private Limited
FY 2024 filings availableCrossandra Pharma Private Limited reported revenue of ₹30.77 Lakh (down 1% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 1% in the latest year, but over three years it has grown at a compounded annual rate (CAGR) of 5%. EBITDA fell 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹93,232 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹68,992 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3% | ||||
| Net Profit Margin | 2.2% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Crossandra Pharma Private Limited, buy the company report.
Board of directors of Crossandra Pharma Private Limited
Crossandra Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sarika Anil Kamble Also directs: Aboli Hospital Private Limited, Grishmaaboli Foundation | Director | 02 Jun 2016 | 10 Years 5 Months | Current |
| Anil Sadashivrao Kamble Also directs: Aboli Hospital Private Limited, Grishmaaboli Foundation | Director | 02 Jun 2016 | 10 Years 5 Months | Current |
Peer comparison
Crossandra Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dunamis Mechatronics Private Limited | ₹30.78 Lakh (FY 2024) | -12.0% | Nashik, Maharashtra, India | |||
| Soundbox Network Private Limited | ₹30.78 Lakh (FY 2025) | -8.0% | Noida, Uttar Pradesh, India | |||
| Das Brothers Pvt Ltd | ₹30.77 Lakh (FY 2024) | 11.0% | Kolkata, West Bengal, India | |||
| Ekadanta Trexim Private Limited | ₹30.77 Lakh (FY 2025) | 621.0% | Delhi, India | |||
| Arcedus Technologies India Private Limited | ₹30.77 Lakh (FY 2024) | 639.0% | Chennai, Tamil Nadu, India | |||
| Crossandra Pharma Private Limitedthis company | ₹30.77 Lakh (FY 2024) | ₹68,992 | 2.2% | -1.0% | Aurangabad, Maharashtra, India | |
| Ram Rahim Farmer Producer Company Limited | ₹30.76 Lakh (FY 2022) | 101.0% | Bihar, India | |||
| Urchoice Lifestyle Private Limited | ₹30.76 Lakh (FY 2025) | -37.0% | Bareilly, Uttar Pradesh, India | |||
| Casual Gardener Private Limited | ₹30.76 Lakh (FY 2024) | 6.0% | Indirapuram, Uttar Pradesh, India | |||
| Banshidhar Distributors Private Limited | ₹30.76 Lakh (FY 2025) | 6.0% | Siliguri, West Bengal, India | |||
| Puncha Agro Producer Company Limited | ₹30.76 Lakh (FY 2025) | 2.0% | Puruliya, West Bengal, India |
To see the full peer comparison of Crossandra Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Crossandra Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Crossandra Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Crossandra Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCC4879C1ZJ | Maharashtra | Active | 17 Jul 2019 |
To see the full GST registrations and return filing status of Crossandra Pharma Private Limited, buy the company report.
Recent activity
Crossandra Pharma Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Anil Sadashivrao Kamble was appointed as Director on 02 Jun 2016.
Frequently asked questions
Crossandra Pharma is an active private limited company based in Aurangabad, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 02 June 2016 (10+ years old) and is registered under CIN U24230MH2016PTC281931.
Crossandra Pharma has 2 current directors:
- Sarika Anil Kamble - Director
- Anil Sadashivrao Kamble - Director
The latest financial statements of Crossandra Pharma on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from FY 2017 are in the company report.
The GSTIN of Crossandra Pharma is 27AAGCC4879C1ZJ, registered in Maharashtra.
The CIN (Corporate Identification Number) of Crossandra Pharma is U24230MH2016PTC281931. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Crossandra Pharma was incorporated on 02 June 2016, making it 10+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Crossandra Pharma by revenue are Dunamis Mechatronics Private Limited, Soundbox Network Private Limited, Das Brothers Pvt Ltd, Ekadanta Trexim Private Limited, Arcedus Technologies India Private Limited and 5 more, all in the same principal business activity (retail trading).
Anil Sadashivrao Kamble was appointed as Director on 02 Jun 2016. Sarika Anil Kamble was appointed as Director on 02 Jun 2016.
The registered office of Crossandra Pharma is at Flat No. 04 S No 82 A – 1 Bldg Ahinsa Nisarga Bhavsing Pura Power House Road Chavani, Aurangabad, Maharashtra, India – 431001.
Crossandra Pharma operates in the chemicals industry, in the manufacturing segment.
The compliance status of Crossandra Pharma is compliant as of 31 August 2026. The company is actively filing with the Registrar of Companies.

